Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2012

01.01.2012 | General Gynecology

Comparison of placental pathology between severe preeclampsia and HELLP syndrome

verfasst von: Ferdous Mehrabian, Fereshteh Mohammadizadeh, Neda Moghtaderi, Alireza Najafian

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study was performed to evaluate and compare the placental pathology in patients with severe pre-eclampsia (PE) and HELLP syndrome. Moreover, neonatal birth weight was compared between the two groups.

Materials and methods

This cross-sectional prospective study was conducted in Alzahra and Beheshti Hospitals (Isfahan, Iran) between 2007 and 2009. Placentas from 32 patients having severe pre-eclampsia without HELLP (referred to as preeclampsia group) and 25 patients having severe preeclampsia with HELLP syndrome (referred to as HELLP group) were evaluated. The studied parameters included placental weight, chorioamnionitis (either acute or chronic), retroplacental hematoma, placental infarction, intervillous thrombosis, and decidual arteriopathy. Birth weight adjusted for gestational age was also compared between the two groups.

Results

We found statistically more significant frequency of retroplacental hematoma in the PE group compared to the HELLP group (P value 0.00). Despite the relatively high frequency of accelerated villous maturation and decidual arteriopathy in both groups, the difference between the two groups regarding these two parameters was not statistically significant. Other placental features did not show any significant difference between the two groups either. The frequency of small for gestational age births showed no statistically significant difference between the two groups.

Conclusion

Retroplacental hematoma was the only placental pathology that showed statistically significant different frequencies between the two groups. Although this may suggest different underlying pathogenetic mechanisms in these two conditions, further studies are needed to confirm this hypothesis.
Literatur
1.
Zurück zum Zitat Lindheimer MD, Taler SJ, Cunningham FG (2010) Hypertension in pregnancy. J Am Soc Hypertens 4(2):68–78PubMedCrossRef Lindheimer MD, Taler SJ, Cunningham FG (2010) Hypertension in pregnancy. J Am Soc Hypertens 4(2):68–78PubMedCrossRef
2.
Zurück zum Zitat Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R (1990) Epidemiology of preeclampsia, eclampsia in the United States, 1979–1986. Am J Obstet Gynecol 163(2):460–465PubMed Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R (1990) Epidemiology of preeclampsia, eclampsia in the United States, 1979–1986. Am J Obstet Gynecol 163(2):460–465PubMed
3.
Zurück zum Zitat Centers for Disease Control, Prevention (CDC) (1998) Maternal mortality–United States, 1982–1996. MMWR Morb Mortal Wkly Rep 47(34):705–707 Centers for Disease Control, Prevention (CDC) (1998) Maternal mortality–United States, 1982–1996. MMWR Morb Mortal Wkly Rep 47(34):705–707
4.
Zurück zum Zitat Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D et al (1995) Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units. Am J Obstet Gynecol 172(2 Pt 1):642–648PubMedCrossRef Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D et al (1995) Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units. Am J Obstet Gynecol 172(2 Pt 1):642–648PubMedCrossRef
5.
Zurück zum Zitat [No authors listed] Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000 183(1):S1–S22 [No authors listed] Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000 183(1):S1–S22
6.
Zurück zum Zitat ACOG Committee on Practice Bulletins–Obstetrics (2002) ACOG practice bulletin. Diagnosis, management of preeclampsia, eclampsia. Number 33, January 2002. Obstet Gynecol 99(1):159–167CrossRef ACOG Committee on Practice Bulletins–Obstetrics (2002) ACOG practice bulletin. Diagnosis, management of preeclampsia, eclampsia. Number 33, January 2002. Obstet Gynecol 99(1):159–167CrossRef
7.
Zurück zum Zitat Goodwin AA, Mercer BM (2005) Does maternal race or ethnicity affect the expression of severe preeclampsia? Am J Obstet Gynecol 193(3 Pt 2):973–978PubMedCrossRef Goodwin AA, Mercer BM (2005) Does maternal race or ethnicity affect the expression of severe preeclampsia? Am J Obstet Gynecol 193(3 Pt 2):973–978PubMedCrossRef
8.
Zurück zum Zitat Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM (1986) Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, low platelets in severe preeclampsia–eclampsia. Am J Obstet Gynecol 155(3):501–509PubMed Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM (1986) Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, low platelets in severe preeclampsia–eclampsia. Am J Obstet Gynecol 155(3):501–509PubMed
9.
10.
Zurück zum Zitat Reubinoff BE, Schenker JG (1991) HELLP syndrome—a syndrome of hemolysis, elevated liver enzymes and low platelet count—complicating preeclampsia–eclampsia. Int J Gynaecol Obstet 36(2):95–102PubMedCrossRef Reubinoff BE, Schenker JG (1991) HELLP syndrome—a syndrome of hemolysis, elevated liver enzymes and low platelet count—complicating preeclampsia–eclampsia. Int J Gynaecol Obstet 36(2):95–102PubMedCrossRef
11.
Zurück zum Zitat Sibai BM (1990) The HELLP syndrome (hemolysis, elevated liver enzymes, low platelets): much ado about nothing? Am J Obstet Gynecol 162(2):311–316PubMed Sibai BM (1990) The HELLP syndrome (hemolysis, elevated liver enzymes, low platelets): much ado about nothing? Am J Obstet Gynecol 162(2):311–316PubMed
12.
Zurück zum Zitat Chang KTE (2009) Pathological examination of the placenta: Raison d’être, clinical relevance and medicolegal utility. Singap Med J 50(12):1123–1133 Chang KTE (2009) Pathological examination of the placenta: Raison d’être, clinical relevance and medicolegal utility. Singap Med J 50(12):1123–1133
13.
Zurück zum Zitat Kim CJ, Romero R, Kusanovic JP, Yoo W, Dong Z, Topping V et al (2010) The frequency, clinical significance, pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol 23(7):1000–1011PubMedCrossRef Kim CJ, Romero R, Kusanovic JP, Yoo W, Dong Z, Topping V et al (2010) The frequency, clinical significance, pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol 23(7):1000–1011PubMedCrossRef
14.
Zurück zum Zitat Ananth CV, Savitz DA, Bowes WA Jr, Luther ER (1997) Influence of hypertensive disorders, cigarette smoking on placental abruption, uterine bleeding during pregnancy. Br J Obstet Gynaecol 104(5):572–578PubMedCrossRef Ananth CV, Savitz DA, Bowes WA Jr, Luther ER (1997) Influence of hypertensive disorders, cigarette smoking on placental abruption, uterine bleeding during pregnancy. Br J Obstet Gynaecol 104(5):572–578PubMedCrossRef
15.
Zurück zum Zitat Ananth CV, Savitz DA, Williams MA (1996) Placental abruption, its association with hypertension, prolonged rupture of membranes: a methodologic review, meta-analysis. Obstet Gynecol 88(2):309–318PubMedCrossRef Ananth CV, Savitz DA, Williams MA (1996) Placental abruption, its association with hypertension, prolonged rupture of membranes: a methodologic review, meta-analysis. Obstet Gynecol 88(2):309–318PubMedCrossRef
16.
Zurück zum Zitat Ananth CV, Peltier MR, Kinzler WL, Smulian JC, Vintzileos AM (2007) Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease? Am J Obstet Gynecol 197(3): 273.e1–273.e7 Ananth CV, Peltier MR, Kinzler WL, Smulian JC, Vintzileos AM (2007) Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease? Am J Obstet Gynecol 197(3): 273.e1–273.e7
17.
Zurück zum Zitat Smulian J, Shen-Schwarz S, Scorza W, Kinzler W, Vintzileos A (2004) A clinicohistopathologic comparison between HELLP syndrome, severe preeclampsia. J Matern Fetal Neonatal Med 16(5):287–293PubMedCrossRef Smulian J, Shen-Schwarz S, Scorza W, Kinzler W, Vintzileos A (2004) A clinicohistopathologic comparison between HELLP syndrome, severe preeclampsia. J Matern Fetal Neonatal Med 16(5):287–293PubMedCrossRef
18.
Zurück zum Zitat Vinnars MT, Wijnaendts LC, Westgren M, Bolte AC, Papadogiannakis N, Nasiell J (2008) Severe preeclampsia with, without HELLP differ with regard to placental pathology. Hypertension 51(5):1295–1299PubMedCrossRef Vinnars MT, Wijnaendts LC, Westgren M, Bolte AC, Papadogiannakis N, Nasiell J (2008) Severe preeclampsia with, without HELLP differ with regard to placental pathology. Hypertension 51(5):1295–1299PubMedCrossRef
19.
Zurück zum Zitat Várkonyi T, Nagy B, Füle T, Tarca AL, Karászi K, Schönléber J et al (2011) Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta 32(Suppl):S21–S29PubMedCrossRef Várkonyi T, Nagy B, Füle T, Tarca AL, Karászi K, Schönléber J et al (2011) Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta 32(Suppl):S21–S29PubMedCrossRef
20.
Zurück zum Zitat von Steinburg SP, Krüger A, Fischer T, Mario Schneider KT, Schmitt M (2009) Placental expression of proteases, their inhibitors in patients with HELLP syndrome. Biol Chem 390(11):1199–1204CrossRef von Steinburg SP, Krüger A, Fischer T, Mario Schneider KT, Schmitt M (2009) Placental expression of proteases, their inhibitors in patients with HELLP syndrome. Biol Chem 390(11):1199–1204CrossRef
21.
Zurück zum Zitat Emanuelli M, Giannubilo SR, Landi B, Sartini D, Pierella F, Corradetti A et al (2008) Placental overexpression of transforming growth factor-beta3 in the HELLP syndrome. Gynecol Obstet Invest 65(1):1–5PubMed Emanuelli M, Giannubilo SR, Landi B, Sartini D, Pierella F, Corradetti A et al (2008) Placental overexpression of transforming growth factor-beta3 in the HELLP syndrome. Gynecol Obstet Invest 65(1):1–5PubMed
Metadaten
Titel
Comparison of placental pathology between severe preeclampsia and HELLP syndrome
verfasst von
Ferdous Mehrabian
Fereshteh Mohammadizadeh
Neda Moghtaderi
Alireza Najafian
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-1948-0

Weitere Artikel der Ausgabe 1/2012

Archives of Gynecology and Obstetrics 1/2012 Zur Ausgabe

Acknowledgement to Referees

Reviewers 2011

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.